Clinical Trials
16
Active:0
Completed:9
Trial Phases
4 Phases
Phase 1:11
Phase 2:1
Phase 3:2
+1 more phases
Drug Approvals
53
PHILIPPINES:53
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Phase 1
11 (68.8%)Phase 3
2 (12.5%)Phase 4
2 (12.5%)Phase 2
1 (6.3%)Drug-drug Interaction Study Between UIC201603, and UIC201604
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: UIC201603 and co-administration of UIC201603 and UIC201604Drug: UIC201604 and co-administration of UIC201603 and UIC201604
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 57
- Registration Number
- NCT06568133
- Locations
- 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of
A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201
Phase 1
Not yet recruiting
- Conditions
- Gastro-Intestinal Disorder
- Interventions
- Drug: UIC202201
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT06393881
- Locations
- 🇰🇷
Chungbuk national university hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: administration of UI068Drug: administration of UIC202205, UIC202206
- First Posted Date
- 2023-11-21
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT06141590
- Locations
- 🇰🇷
H plus Yangji Hospital, Seoul, Gwanak-gu, Korea, Republic of
A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects
- First Posted Date
- 2023-11-21
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT06141577
- Locations
- 🇰🇷
Chungbuk national university hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects
Phase 1
Completed
- Conditions
- GERD
- Interventions
- Drug: administration of UI058Drug: administration of UIC202004
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Korea United Pharm. Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT05282914
- Locations
- 🇰🇷
Chungbuk national university hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
- Prev
- 1
- 2
- 3
- Next
News
No news found